What is New on Diabetic Neuropathy? Insights from the 2023 ADA and EASD Conferences
Diabetic neuropathy is a common complication of diabetes; yet its pathophysiology is still incompletely understood and until today, there is no specific treatment against it. In the two 2023 large congresses on diabetes (American Diabetes Association, ADA, European Association for the Study of Diabetes, EASD), several high-level studies have been presented. They have attempted to delineate the pathophysiology of DN, the characteristics of affected patients, and future potential treatments. We herein review the presented studies on diabetic neuropathy at these diabetes congresses and discuss the needs for future research on this topic.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
---|---|
Enthalten in: |
The international journal of lower extremity wounds - (2024) vom: 28. Feb., Seite 15347346241233938 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Rebelos, Eleni [VerfasserIn] |
---|
Links: |
---|
Themen: |
Advanced glycation end products |
---|
Anmerkungen: |
Date Revised 28.02.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.1177/15347346241233938 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369043022 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM369043022 | ||
003 | DE-627 | ||
005 | 20240229171639.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240229s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1177/15347346241233938 |2 doi | |
028 | 5 | 2 | |a pubmed24n1310.xml |
035 | |a (DE-627)NLM369043022 | ||
035 | |a (NLM)38414376 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Rebelos, Eleni |e verfasserin |4 aut | |
245 | 1 | 0 | |a What is New on Diabetic Neuropathy? Insights from the 2023 ADA and EASD Conferences |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 28.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a Diabetic neuropathy is a common complication of diabetes; yet its pathophysiology is still incompletely understood and until today, there is no specific treatment against it. In the two 2023 large congresses on diabetes (American Diabetes Association, ADA, European Association for the Study of Diabetes, EASD), several high-level studies have been presented. They have attempted to delineate the pathophysiology of DN, the characteristics of affected patients, and future potential treatments. We herein review the presented studies on diabetic neuropathy at these diabetes congresses and discuss the needs for future research on this topic | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Charcot neuroarthropathy | |
650 | 4 | |a advanced glycation end products | |
650 | 4 | |a cardiac autonomic neuropathy | |
650 | 4 | |a diabetes | |
650 | 4 | |a diabetic neuropathy | |
700 | 1 | |a Anastasiou, Ioanna A |e verfasserin |4 aut | |
700 | 1 | |a Tentolouris, Anastasios |e verfasserin |4 aut | |
700 | 1 | |a Papanas, Nikolaos |e verfasserin |4 aut | |
700 | 1 | |a Jude, Edward |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The international journal of lower extremity wounds |d 2002 |g (2024) vom: 28. Feb., Seite 15347346241233938 |w (DE-627)NLM155083767 |x 1552-6941 |7 nnns |
773 | 1 | 8 | |g year:2024 |g day:28 |g month:02 |g pages:15347346241233938 |
856 | 4 | 0 | |u http://dx.doi.org/10.1177/15347346241233938 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2024 |b 28 |c 02 |h 15347346241233938 |